Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00083070

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Fairview University Medical Center - University Campus Minneapolis, Minnesota, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View all 16 locations
View Trial Details
Completed

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

NCT00002485

Conditions
Adnexal Diseases, Astrocytoma, Brain Diseases, +96 more
Locations
  • University of California Davis Medical Center Sacramento, California, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • CCOP - Florida Pediatric Tampa, Florida, United States
View all 31 locations
View Trial Details
Completed

Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00002756

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 140 locations
View Trial Details
Completed

Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only

NCT00950911

Conditions
Blood Protein Disorders, Bone Metastases in Men With Hormone-Refractory Prostate Cancer, Bone Metastases in Subjects With Advanced Breast Cancer, +28 more
Locations
  • Research Site Jindřichův Hradec, Czechia
  • Research Site Kroměříž, Czechia
  • Research Site Olomouc, Czechia
  • Research Site Prague, Czechia
View all 17 locations
View Trial Details

Related conditions